These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3180122)

  • 1. Immunogenetic heterogeneity of uveal melanoma.
    Martinetti M; Tafi A; De Paoli F; Dugoujon JM; Belvedere MC
    Cancer Detect Prev; 1988; 12(1-6):145-8. PubMed ID: 3180122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
    Metzelaar-Blok JA; Hurks HM; Naipal A; De Lange P; Keunen JE; Claas FH; Doxiadis II; Jager MJ
    Mol Vis; 2005 Dec; 11():1166-72. PubMed ID: 16379028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
    Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
    Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uveal melanoma: no expression of HLA-G.
    Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of HLA genotype with inflammation in uveal melanoma.
    van Essen TH; Bronkhorst IH; Maat W; Verduyn W; Roelen DL; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2640-6. PubMed ID: 22447860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
    Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
    Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients.
    Metzelaar-Blok JA; ter Huurne JA; Hurks HM; Keunen JE; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1951-4. PubMed ID: 11481256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
    Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC
    Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2A as a uveal and cutaneous melanoma susceptibility gene.
    Kannengiesser C; Avril MF; Spatz A; Laud K; Lenoir GM; Bressac-de-Paillerets B
    Genes Chromosomes Cancer; 2003 Nov; 38(3):265-8. PubMed ID: 14506702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
    Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2153-6. PubMed ID: 11527924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
    Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
    Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of classic and nonclassic HLA class I antigens in uveal melanoma.
    Anastassiou G; Rebmann V; Wagner S; Bornfeld N; Grosse-Wilde H
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2016-9. PubMed ID: 12714638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.
    Anichini A; Mortarini R; Nonaka D; Molla A; Vegetti C; Montaldi E; Wang X; Ferrone S
    Cancer Res; 2006 Jun; 66(12):6405-11. PubMed ID: 16778219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
    Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
    Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.